Literature DB >> 33654921

SarkoSpin: A Technique for Biochemical Isolation and Characterization of Pathological TDP-43 Aggregates.

Manuela Pérez-Berlanga1, Florent Laferrière1, Magdalini Polymenidou1.   

Abstract

TDP-43 is the main aggregating protein in neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Aggregated TDP-43 is resistant to diverse detergent solubilization, yet physiological TDP-43 and other abundant proteins commonly co-purify with pathological TDP-43. This mixed isolation has precluded the elucidation of the biochemical and structural features of the pathological TDP-43 and its role in disease. Here we describe SarkoSpin, a method for the isolation of pure pathological TDP-43 from patient autopsy brain by sample solubilization with Sarkosyl after nuclease treatment. This purification, which is also applicable to cell culture material, permits the study of biochemical properties of exclusively pathological TDP-43, allowing for the first time the determination of their link to the clinical presentation of FTLD. This method opens up a path for the study of pathological TDP-43 at the molecular and structural level in the heterogeneous spectrum of ALS and FTLD cases.
Copyright © 2019 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  ALS; Aggregation; FTLD; SarkoSpin; TDP-43

Year:  2019        PMID: 33654921      PMCID: PMC7853943          DOI: 10.21769/BioProtoc.3424

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  8 in total

Review 1.  Unfolding the role of protein misfolding in neurodegenerative diseases.

Authors:  Claudio Soto
Journal:  Nat Rev Neurosci       Date:  2003-01       Impact factor: 34.870

2.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

3.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Tetsuaki Arai; Masato Hasegawa; Haruhiko Akiyama; Kenji Ikeda; Takashi Nonaka; Hiroshi Mori; David Mann; Kuniaki Tsuchiya; Mari Yoshida; Yoshio Hashizume; Tatsuro Oda
Journal:  Biochem Biophys Res Commun       Date:  2006-10-30       Impact factor: 3.575

Review 4.  Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis.

Authors:  Shuo-Chien Ling; Magdalini Polymenidou; Don W Cleveland
Journal:  Neuron       Date:  2013-08-07       Impact factor: 17.173

5.  TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates.

Authors:  Florent Laferrière; Zuzanna Maniecka; Manuela Pérez-Berlanga; Marian Hruska-Plochan; Larissa Gilhespy; Eva-Maria Hock; Ulrich Wagner; Tariq Afroz; Paul J Boersema; Gery Barmettler; Sandrine C Foti; Yasmine T Asi; Adrian M Isaacs; Ashraf Al-Amoudi; Amanda Lewis; Henning Stahlberg; John Ravits; Francesca De Giorgi; François Ichas; Erwan Bezard; Paola Picotti; Tammaryn Lashley; Magdalini Polymenidou
Journal:  Nat Neurosci       Date:  2018-12-17       Impact factor: 24.884

6.  Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration.

Authors:  Edward B Lee; Sílvia Porta; G Michael Baer; Yan Xu; EunRan Suh; Linda K Kwong; Lauren Elman; Murray Grossman; Virginia M-Y Lee; David J Irwin; Vivianna M Van Deerlin; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2017-01-27       Impact factor: 17.088

7.  Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation.

Authors:  Tariq Afroz; Eva-Maria Hock; Patrick Ernst; Chiara Foglieni; Melanie Jambeau; Larissa A B Gilhespy; Florent Laferriere; Zuzanna Maniecka; Andreas Plückthun; Peer Mittl; Paolo Paganetti; Frédéric H T Allain; Magdalini Polymenidou
Journal:  Nat Commun       Date:  2017-06-29       Impact factor: 14.919

8.  Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.

Authors:  E Buratti; T Dörk; E Zuccato; F Pagani; M Romano; F E Baralle
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

  8 in total
  1 in total

1.  FTLD-TDP assemblies seed neoaggregates with subtype-specific features via a prion-like cascade.

Authors:  Pierre De Rossi; Amanda J Lewis; Johanna Furrer; Laura De Vos; Tomas Demeter; Aurélie Zbinden; Weijia Zhong; Vera I Wiersma; Carlo Scialo; Julien Weber; Zhongning Guo; Stefano Scaramuzza; Marta Di Fabrizio; Carolin Böing; Daniel Castaño-Díez; Ashraf Al-Amoudi; Manuela Pérez-Berlanga; Tammaryn Lashley; Henning Stahlberg; Magdalini Polymenidou
Journal:  EMBO Rep       Date:  2021-11-22       Impact factor: 8.807

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.